Janssen Immunosciences, World Without Disease Accelerator, Pharmaceutical Companies of Johnson & Johnson, Beerse, 2340, Belgium.
Janssen Immunosciences, World Without Disease Accelerator, Pharmaceutical Companies of Johnson & Johnson, Beerse, 2340, Belgium; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, 9000, Belgium.
Immunity. 2019 Jun 18;50(6):1352-1364. doi: 10.1016/j.immuni.2019.05.020.
Caspases are an evolutionary conserved family of cysteine proteases that are centrally involved in cell death and inflammation responses. A wealth of foundational insight into the molecular mechanisms that control caspase activation has emerged in recent years. Important advancements include the identification of additional inflammasome platforms and pathways that regulate activation of inflammatory caspases; the discovery of gasdermin D as the effector of pyroptosis and interleukin (IL)-1 and IL-18 secretion; and the existence of substantial crosstalk between inflammatory and apoptotic initiator caspases. A better understanding of the mechanisms regulating caspase activation has supported initial efforts to modulate dysfunctional cell death and inflammation pathways in a suite of communicable, inflammatory, malignant, metabolic, and neurodegenerative diseases. Here, we review current understanding of caspase biology with a prime focus on the inflammatory caspases and outline important topics for future experimentation.
Caspases 是一组进化上保守的半胱氨酸蛋白酶家族,它们在细胞死亡和炎症反应中起着核心作用。近年来,人们对控制半胱天冬酶激活的分子机制有了大量的基础性认识。重要的进展包括鉴定了额外的炎症小体平台和途径,这些平台和途径调节炎症半胱天冬酶的激活;发现了gasdermin D 作为细胞焦亡和白细胞介素 (IL)-1 和 IL-18 分泌的效应物;以及炎症和凋亡起始半胱天冬酶之间存在大量的串扰。对半胱天冬酶激活调节机制的更好理解,支持了最初在一系列传染性、炎症性、恶性、代谢性和神经退行性疾病中调节功能失调的细胞死亡和炎症途径的努力。在这里,我们综述了对半胱天冬酶生物学的现有理解,主要关注炎症半胱天冬酶,并概述了未来实验的重要课题。